Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00984841 · ClinicalTrials.gov registry record · NA
Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?
A NA study of Diabetes Mellitus, sponsored by Scranton-Temple Residency Program.
- Completed
- Registry status
- NA
- Development phase
- 467
- Enrollment target
- 1
- Study location
NCT00984841 is a NA study of Diabetes Mellitus that has completed, run by Scranton-Temple Residency Program. The registered enrollment target is 467 participants, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00984841, a NA study of Diabetes Mellitus, has completed, sponsored by Scranton-Temple Residency Program.
- COMPLETED
- Registry status
- NA
- Development phase
- 467 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.
Conditions Studied
Interventions
- OTHER Tailored letter
Study Locations (1)
Pennsylvania
- Scranton-Temple Health Center - Scranton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 467 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00984841
The ClinicalTrials.gov registry entry for NCT00984841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 467 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (75% lower). The listed sponsor is Scranton-Temple Residency Program, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Tailored letter is the first listed.
NCT00984841 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00984841 about?
NCT00984841 is a clinical study titled "Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?". The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.
What is the current status of trial NCT00984841?
This trial is currently completed. It is a NA study. The enrollment target is 467 participants. The study started on 2009-01. Estimated completion is 2009-07.
What conditions does trial NCT00984841 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT00984841?
The interventions under investigation include: Tailored letter (OTHER).
Who is sponsoring clinical trial NCT00984841?
This trial is sponsored by Scranton-Temple Residency Program, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00984841 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.